Transfusion-transmitted human immunodeficiency virus (HIV) from seroconverting donors is rare in England and Wales: results from HIV lookback, October 1995 through December 2008. (Q33777205)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Transfusion-transmitted human immunodeficiency virus (HIV) from seroconverting donors is rare in England and Wales: results from HIV lookback, October 1995 through December 2008.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Transfusion-transmitted human immunodeficiency virus (HIV) from seroconverting donors is rare in England and Wales: results from HIV lookback, October 1995 through December 2008. (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

HIV transmission

0 references

author name string

Lisa Byrne

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Lisa J Brant

2

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Katy Davison

3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Patricia Hewitt

4

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

publication date

22 December 2010

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

51

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1339-1345

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Sensitivity of two hepatitis B virus, hepatitis C virus (HCV), and human immunodeficiency virus (HIV) nucleic acid test systems relative to hepatitis B surface antigen, anti-HCV, anti-HIV, and p24/anti-HIV combination assays in seroconversion panels

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02996.X

21 January 2018

Performance of three automated fourth-generation combined HIV antigen/antibody assays in large-scale screening of blood donors and clinical samples.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02996.X

21 January 2018

Recent Canadian experience with targeted hepatitis C virus lookback

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02996.X

21 January 2018

The value of lookback to understanding blood-borne infectious diseases: the New South Wales' HIV experience

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02996.X

21 January 2018

Experience of mandatory nucleic acid test (NAT) screening across all blood organizations in Germany: NAT yield versus breakthrough transmissions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02996.X

21 January 2018

Improvement in the performance of HIV screening kits

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02996.X

21 January 2018

A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02996.X

21 January 2018

Window-period human immunodeficiency virus transmission to two recipients by an adolescent blood donor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02996.X

21 January 2018

Failure of routine HIV-1 tests in a case involving transmission with preseroconversion blood components during the infectious window period

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02996.X

21 January 2018

First report of human immunodeficiency virus transmission via an RNA-screened blood donation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02996.X

21 January 2018

Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02996.X

21 January 2018

Surveillance of risk profiles among new and repeat blood donors with transfusion-transmissible infections from 1995 through 2003 in the Netherlands

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02996.X

21 January 2018

Risk factors for HCV infection among blood donors confirmed to be positive for the presence of HCV RNA and not reactive for the presence of anti-HCV.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02996.X

21 January 2018

Paving with good intentions: learning from HCV lookback.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02996.X

21 January 2018

Hepatitis B virus traceback and lookback: factors to consider

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02996.X

21 January 2018

Effectiveness of human T-lymphotropic virus (HTLV) recipient tracing (lookback) and the current HTLV-I and -II confirmatory algorithm, 1999 to 2004.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02996.X

21 January 2018

Identifiers

10.1111/J.1537-2995.2010.02996.X

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33777205&oldid=1952739357"